A243V
Category 4 — Stable Fold, Function DisruptedConflictingCytoplasmic · predictedEditorialAlanine → Valine at position 243 in N-terminal cytoplasmic domain. ClinVar Conflicting including monogenic diabetes. AlphaMissense 0.27 (below threshold) — AM under-call. DynaMut2 ΔΔG -0.93.
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | D246 | D246 | Preserved |
| Hydrogen bond | F247 | F247 | Preserved |
| Polar contact | D245 | — | Lost |
| Polar contact | D246 | D246 | Preserved |
| Polar contact | F247 | F247 | Preserved |
| Van der Waals | D245 | — | Lost |
| Van der Waals | — | F247 | Gained |
| Hydrophobic | Q194 | Q194 | Preserved |
| Hydrophobic | — | D246 | Gained |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed in the general population.
Structural Context
Position 243 in cytoplasmic domain. Neighbors: LEU244 (2.5 Å), ILE242 (2.5 Å), LYS193 (4.0 Å — long-range contact!). The K193 long-range contact suggests A243 sits in a structural element bringing distant sequence positions into contact.
|ΔΔG| 0.93 substantial for conservative substitution. AM 0.27 under-call; monogenic diabetes confirms pathogenicity.
Druggability Assessment
Mechanism: volume mismatch perturbing K193 long-range contact. Therapeutic: site-directed at the 193-243 cross-fold geometry.
Why this matters
Feed this card to Wolfram Intelligence
Download the A243V PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.